Filing Details

Accession Number:
0001104659-23-088491
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-07 21:17:03
Reporting Period:
2023-08-03
Accepted Time:
2023-08-07 21:17:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1657312 Verona Pharma Plc VRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408502 W Mark Hahn 3 More London Riverside
London X0 SE1 2RE
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-08-03 117,272 $2.54 15,679,864 No 4 S Direct
Ordinary Shares Disposition 2023-08-04 150,000 $2.50 15,529,864 No 4 S Direct
Ordinary Shares Disposition 2023-08-07 8,616 $2.47 15,521,248 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  2. The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
  3. The price reported represents the sale price of the ADSs divided by eight (8).
  4. Consists of (i) 5,911,816 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 738,977 ADSs); and (ii) 9,609,432 Ordinary Shares underlying 1,201,179 ADSs.